# Extension Study for 2993-112

> **NCT01789957** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 225 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** AC2993

## Key facts

- **NCT ID:** NCT01789957
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2004-06
- **Final completion:** 2004-06
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2015-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01789957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01789957, "Extension Study for 2993-112". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01789957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*